Ba Zhen Yi Mu Wan
Natural health product licensed in Canada
- Licence holder
- T.C. Unicorn Ltd.
- NPN or DIN-HM
- 80001628
- Status
- Active licence
- Licence date
- 24 April 2006
- Revision date
- Not provided
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycyrrhiza uralensis Extraction ratio : 3.35:1 Dry plant equivalent : 13.88 mg | 4.12 mg | Not calculated |
| Poria cocos Extraction ratio : 1.11:1 Dry plant equivalent : 27.79 mg | 25 mg | Not calculated |
Non-medicinal ingredients
Amidon
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 8 Comprimé | 3 Tous les jours |
Uses authorised in Canada
This traditional Chinese medicine helps replenish qi and blood. It is used for deficiency of qi and blood in women with general weakness
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Contraindicated in hemoptysis.
Source
Official Health Canada record, licence 80001628
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.